Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug combo aims to keep ovarian cancer at bay longer

NCT ID NCT07225270

Recruiting now Disease control Sponsor: Genmab Source: ClinicalTrials.gov ↗

Summary

This study is testing whether adding an investigational drug called Rina-S to standard maintenance therapy can help delay the return of ovarian cancer in people whose cancer has come back but still responds to platinum chemotherapy. About 528 participants with recurrent platinum-sensitive ovarian cancer will receive either Rina-S (alone or with bevacizumab) or standard care alone after completing their second-line chemotherapy. The main goal is to see if the Rina-S combinations help people live longer without their cancer getting worse.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hyogo Cancer Center

    RECRUITING

    Akashi, Hyōgo, Japan

  • Miami Valley Hospital South

    RECRUITING

    Centerville, Ohio, 45459, United States

  • Mie University Graduate School Of Medicine

    RECRUITING

    Tsu, Mie-ken, Japan

  • Mt. Sinai Comprehensive Cancer Center

    RECRUITING

    Miami, Florida, 33140, United States

  • National Hospital Organization Hokkaido Cancer Center

    RECRUITING

    Sapporo, Hokkaido, Japan

  • Niigata University Medical & Dental Hospital

    RECRUITING

    Niigata, Japan

  • Osaka Medical and Pharmaceutical University Hospital

    RECRUITING

    Takatsuki, Osaka, Japan

  • Saitama Medical University International Medical Center

    RECRUITING

    Hidaka, Saitama, Japan

  • The Cancer Institute Hospital of JFCR

    RECRUITING

    Tokyo, Japan

Conditions

Explore the condition pages connected to this study.

OVARIAN CANCER PLATINUM-SENSITIVE OVARIAN CANCER PSOC